UM
RMD icon

UniSuper Management’s ResMed RMD Stock Holding History

UniSuper Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6M Buy
74,692
+12,363
+20% +$2.56M 0.08% 151
2026
Q1 		$14M Sell
62,329
-4,801
-7% -$1.2M 0.09% 140
2025
Q4 		$16.2M Sell
67,130
-2,117
-3% -$541K 0.1% 131
2025
Q3 		$19M Buy
69,247
+3,818
+6% +$1.04M 0.12% 128
2025
Q2 		$16.9M Sell
65,429
-755
-1% -$180K 0.11% 131
2025
Q1 		$14.8M Buy
66,184
+574
+0.9% +$134K 0.11% 131
2024
Q4 		$15M Buy
65,610
+2,138
+3% +$515K 0.11% 128
2024
Q3 		$15.5M Buy
63,472
+731
+1% +$163K 0.12% 128
2024
Q2 		$12M Buy
62,741
+3,641
+6% +$739K 0.1% 132
2024
Q1 		$11.7M Buy
59,100
+5,271
+10% +$966K 0.11% 128
2023
Q4 		$9.26M Sell
53,829
-739
-1% -$114K 0.1% 143
2023
Q3 		$8.07M Sell
54,568
-260
-0.5% -$47K 0.1% 145
2023
Q2 		$12M Buy
+54,828
New +$12.2M 0.14% 119

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UniSuper Management's RMD Position: Q2 2026 in Review

UniSuper Management increased its ResMed (RMD) stake by 20% in Q2 2026, buying an estimated $2.56M and bringing the position to 74,692 shares worth $14.6M. The position accounts for 0.08% of the portfolio, ranked #151.

UniSuper Management first reported a position in RMD in Q2 2023 and has held it in 13 quarters since. The position peaked at $19M in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • UniSuper Management held 74,692 shares of ResMed worth $14.6M as of Q2 2026.
  • UniSuper Management bought 12,363 ResMed shares in Q2 2026, an estimated $2.56M.
  • ResMed made up 0.08% of UniSuper Management's portfolio in Q2 2026, its #151 holding.
  • UniSuper Management first reported a position in ResMed in Q2 2023 and has held it in 13 quarters since.
  • UniSuper Management's ResMed position peaked at $19M in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.